Drug Profile
Research programme: clofarabine - Heidelberg Pharma Research
Alternative Names: Clofarabine-EPD; EPD-clofarabine; HDP 15.0022Latest Information Update: 06 Oct 2021
Price :
$50
*
At a glance
- Originator Heidelberg Pharma
- Developer Heidelberg Pharma Research
- Class Antineoplastics; Antipsoriatics; Furans; Purine nucleosides; Small molecules
- Mechanism of Action Apoptosis stimulants; DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Solid tumours
Most Recent Events
- 09 Oct 2017 Heidelberg Pharma is now called Heidelberg Pharma Research
- 28 Feb 2011 Heidelberg Pharma has been acquired by Wilex
- 15 Nov 2010 Suspended - Preclinical for Solid tumours in Germany (PO) before November 2010